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Abstract. Muramic acid is found in many peptide natural products containing oligo(poly)saccharide moie-
ties. Taking into consideration that the Fmoc methodology is routinely used for solid-phase peptide syn-
thesis, preparation of orthogonally protected muramic acid building blocks for total solid-phase synthesis 
of these natural products is of particular practical importance. Herein a simple and efficient synthesis  
of benzyl 2-amino-4,6-O-benzylidene-3-O-[(R)-1-carboxyethyl]-2-deoxy-N-9-fluorenylmethyloxycarbonyl-
α-D-glucopyranoside (6) from N-acetylglucosamine (1) is described. Important improvements over previ-
ous synthetic approaches to glucopyranosides 2 (benzyl 2-acetamido-2-deoxy-α-D-glucopyranoside) and 3 
(benzyl 2-acetamido-4,6-O-benzylidene-2-deoxy-α-D-glucopyranoside), key building blocks in prepara-
tion of 6, include synthesis simplification and efficient isolation and purification. Optically pure (S)-2-
chloropropionic acid 7 was prepared and introduced to the positon 3-O of sugar moiety to give compound 
4 (benzyl 2-acetamido-4,6-O-benzylidene-3-O-[(R)-1-carboxyethyl]-2-deoxy-α-D-glucopyranoside) with 
the (R)-configuration of the lactyl side-chain in excellent overall yield and optical purity. Deacetylation of 
amino group gave compound 5 (benzyl 2-amino-4,6-O-benzylidene-3-O-[(R)-1-carboxyethyl]-2-deoxy-α-
D-glucopyranoside) suitable for incorporation of the Fmoc protecting group to give protected muramic ac-
id derivative 6, a useful building block in peptide synthesis. 
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INTRODUCTION 
Sugar amino acids (SAAs) are defined as carbohy-
drate-based compounds that feature an amine and a 
carboxylate.1–7 As such, SAAs are widely spread in 
nature, and neuraminic acid and N-acetylmuramic acid 
constitute important structural elements in many oligo-
(poly)saccharides and glycoconjugates.1 Muramic acid 
has been shown to be the main component of the 
peptidoglycan chain, which constitutes a building unit 
of the bacterial cell walls and spores.8 The discovery 
that the minimal adjuvant active structure of bacterial 
peptidoglycans is the muramyl dipeptide N-acetyl-
muramyl-L-alanyl-D-isoglutamine (MDP) has generat-
ed a great deal of interest in muramic acid derivatives 
preparation.9,10 The potential utilisation of a simple 
and well-defined synthetic adjuvant molecule as MDP, 
showing maximal stimulation of the immune response 
but little toxicity and other side effects, has heralded a 
new era in immunology especially in the field of new 
vaccine development.11 Interestingly, SAAs in nature 
are almost exclusively linked through interglycosidic 
bonds, not through amide bonds. The relevance of the 
hybrid nature of SAAs is evident by the multitude of 
reported applications in which selected amino acid 
residues are replaced by SAA in biologically relevant 
oligopeptides. Thus the outcome of this replacement 
can be twofold: 1) The nature of the parent carbohy-
drate (the furan or pyran ring) in combination with the 
positioning of the amine and carboxylate may affect a 
desired secondary structure on the target oligopeptide, 
2) the residual functionalities on the furan/pyran core 
may be used to introduce additional desirable proper-
ties to the peptide.12 Despite the growing interest for 
the use of SAAs in preparation of unusual peptides 
with unique structural and biological properties, there 
is no reported strategy that describes efficient synthe-
sis of orthogonally protected SAA suitable for the 
Fmoc-solid phase peptide synthesis.13–18 Herein we 
describe the synthesis of optically pure orthogonally 
protected muramic acid were the impurities of the 
isomuramic acid were avoided by using optically pure 
(S)-2-chloropropionic acid for introduction of lactyl 
group to sugar moiety. 
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EXPERIMENTAL 
Melting points were determined on a Tottoli (Büchi) 
apparatus and are uncorrected. Optical rotations were 
measured at 25 °C using an Optical Activity LTD auto-
matic AA-10 polarimeter. NMR spectra were recorded 
on a Bruker AV 600 spectrometer, operating at 150.91 
MHz for 13C and 600.13 MHZ for 1H nuclei. The spec-
tra were measured in DMSO-d6 and CDCl3 solutions at 
25 °C. Chemical shifts in parts per million were refer-
enced to tetrametylsilane (TMS) and expressed in ppm. 
Spectra were assigned based one dimensional 1H, 13C 
and APT (Attached Proton Test) and 2D homonuclear 
COSY (Correlation Spectroscopy) and heteronuclear 
HMQC (Heteronuclear Multiple-Quantum Correlation) 
and HMBC (Heteronuclear Multiple Bond Correlation) 
experiments. Mass spectra were recorded on a triple 
quadrupole Agilent 6410 spectrometer operating in 
Electrospray ionization (ESI) mode. Analytical TLC 
was carried out on silica gel 60 with detection by char-
ring with 10 % H2SO4. Column chromatography was 
performed on silica gel (Merck, 0.040–0.063 mm). 
Following solvent systems were used: A) EtOAc : EtOH: 
HOAc : H2O = 70 : 10 : 2 : 2 v/v/v/v; B) EtOAc : HOAc : 
H2O = 70 : 2 : 2 v/v/v; C) CH2Cl2 : MeOH = 9 : 1 v/v; D) 
EtOAc : HOAc : H2O = 70 : 1 : 1 v/v/v; E) EtOAc : EtOH: 
HOAc: H2O = 70: 20 : 2 : 2 v/v/v/v. N-acetylglucosamine 
(1), benzyl alcohol, p-toluene sulfonic acid monohydra-
te, benzaldehyde, Fmoc-OSu, NaH and ZnCl2 were pur-
chased from Sigma-Aldrich.  
 
Benzyl 2-acetamido-2-deoxy-α-D-glucopyranoside (2)19 
N-acetylglucosamine (1) (10 g, 0.045 mol) and benzyl 
alcohol (72 mL) were suspended in toluene (120 mL) 
and p-toluene sulfonic acid monohydrate (500 mg) was 
added. The reaction mixture was refluxed (130 °C) in a 
Dean-Stark apparatus with water removal by azeotropic 
mixture. After 4 h, the reaction mixture was cooled to 
ambient temperature and saturated solution of sodium 
hydrogen carbonate was added to pH ~ 6. Toluene was 
removed under reduced pressure. Residue was split into 
ether-hexane (vol. ratio = 2:1, 260 mL) mixture. Reac-
tion mixture was vigorously stirred for 3h and left over-
night in refrigerator. The amorphous precipitate was 
filtered off, washed with ether and the crude product re-
crystallized from 2-propanol to yield colourless crystals 
2 (10.1 g, 72% yield). Rf (A) = 0.42; m.p. 186–187 °C 
(lit. 185–186 °C)20; [α]D = +170 ° c 1, water (lit. [α]D = 
+168 ° c 1, water)20; 1H NMR (DMSO-d6) δ /ppm: 7.81 
(d, 1H, J = 8.2 Hz, NH), 7.35–7.28 (m, 5H, Ph), 5.01 (d, 
1H, J = 5.8 Hz, OH-4), 4.73 (d, 1H, J = 5.8 Hz, OH-3), 
4.70 (d, 1H, J = 3.2 Hz, H-1), 4.66 (d, 1H, J = 12.3 Hz, 
CH2b-Ph), 4.54 (t, 1H, J = 5.8 Hz, OH-6), 4.41 (d, 1H, 
J = 12.3 Hz, CH2a-Ph), 3.68 (m, 1H, H-2), 3.65 (m, 1H, 
H-6b), 3.53 (m, 1H, H-3), 3.50 (m, 1H, H-6a), 3.45 (m, 
1H, H-5), 3.16 (m, 1H, H-4), 1.83 (s, 3H, CH3-CON 
acetyl); 13C NMR (DMSO-d6) δ /ppm: 169.4 (CO ace-
tyl), 137.9 (Ph (C)), 128.1–127.4 (Ph(CH)), 95.9 (C-1), 
73.1 (C-5), 70.9 (C-4), 70.6 (C-3), 67.7 (CH2-Ph), 60.8 
(C-6), 53.7 (C-2), 22.5 (CH3-CON acetyl); MS-ESI m/z 
312 [M+H]+. 
 
Benzyl 2-acetamido-4,6-O-benzylidene-2-deoxy-α-D-gluco-
pyranoside (3)21 
Suspension of compound 2 (6 g, 0.019 mol), benzalde-
hyde (100 mL) and anhydrous ZnCl2 (6 g) was stirred at 
room temperature for 16 h. Solution was spilt in ice-
cold water-petrol ether mixture (80 mL: 60 mL). Solu-
tion was mixed for additional 15 min, after which the 
formed precipitate was filtrated, washed with water and 
hexane. Crude product was recrystallized from mixture 
of 2-propanol (50 mL) and dioxane (20 mL) and crys-
tals were filtrated and washed with cold 2-propanol  
to give compound 3 (6.1 g, 80 % yield). Rf (B) = 0.72; 
m.p. 240–242 °C (lit. 263–264 °C)21; [α]D = +110 ° c 1, 
pyridine (lit. [α]D = +108 ° c 1, pyridine)22; 1H NMR 
(DMSO-d6) δ /ppm: 7.97 (d, 1H, J = 8.3 Hz, NH), 7.46–
7.30 (m, 10H, Ph), 5.62 (s, 1H, CH-Ph) 5.16 (d, 1H, 
J = 5.8 Hz, OH-3), 4.80 (d, 1H, J = 3.6, H-1), 4.69  
(d, 1H, J = 12.3 Hz, CH2b-Ph), 4.48 (d, 1H, J = 12.3 Hz, 
CH2a-Ph), 4.14 (m, 1H, H-6b), 3.84 (m, 1H, H-2),  
3.74–7.71 (m, 2H, H-3, H-6a), 3.69 (m, 1H, H-5), 3.51 
 
Figure 1. Synthesis of protected muramic derivative 6 from 
N-acetylglucosamine (1). Reagents and conditions: BnOH, 
toluene, p-toluene sulfonic acid monohydrate, 130 °C, 4 h (a); 
benzaldehyde, ZnCl2,16 h (b); NaH, 70 °C, 24 h (c); 5 M KOH, 
120 °C,16 h (d); Fmoc-OSu, DMF, NaHCO3, 0 °C, 2 h (e). 
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(t, 1H, J = 8.8 Hz, H-4), 1.84 (s, 3H, CH3-CON acetyl); 
13C NMR (DMSO-d6) δ /ppm: 169.4 (CO acetyl),  
137.7 (Ph(C)), 129.2–126.4 (Ph(CH)), 100.8 (CH-Ph), 
96.9 (C-1), 82.1 (C-4), 68.6 (CH2-Ph), 68.0 (C-6), 67.2  
(C-3), 62.8 (C-5), 54.2 (C-2), 22.5 (CH3-CON acetyl); 
MS-ESI m/z 400 [M+H]+. 
 
Benzyl 2-acetamido-4,6-O-benzylidene-3-O-[(R)-1-carboxy-
ethyl]-2-deoxy-α-D-glucopyranoside (4)23 
Compound 3 (4g, 0.010 mol) was dissolved in anhy-
drous dioxane (170 mL) and stirred at 80–90 °C until 
dissolved. The temperature was lowered to 70 °C and 
NaH (3.1 g, 0.130 mol, 80 % oil dispersion) in small 
portions was added to solution. Reaction mixture was 
stirred for 1 h at 95 °C then cooled to 65 °C, and solu-
tion of (S)-2-chloropropionic acid (7, 3.2 g, 0.030 mol) 
in anhydrous dioxane (10 mL) was added dropwise. 
After 1h stirring at 65 °C the additional amount of NaH 
(1.9 g, 0.080 mol) was added and reaction mixture was 
stirred at 70 °C for 24 h. Reaction mixture was cooled in 
ice-water bath and ice cold water was added dropwise. 
After the extraction upper light yellow layer was filtrat-
ed and dioxane was evaporated in vacuum to 30 mL. 
The residue was dissolved in water (50 mL) and ex-
tracted with dichloromethane (DCM, 2 × 20 mL). Or-
ganic layer was washed with 20 mL water. Water layers 
were cooled to 0 °C and adjusted to pH = 3 (2 M HCl) 
and stirred for 15 min. The precipitated product was 
washed with ice cold water and evaporated. Crude 
product was purified by flash silica gel column chroma-
tography in solvent system C to give compound 4 (3.7 
g, 78 % yield) white amorphous crystalline. Rf (D) = 
0.52; m.p. 238–240 °C (lit. 237–239 °C)22; [α]D =  
+133 ° c 1, MeOH (lit. [α]D = +117 ° c 0.5, MeOH)22;  
1H NMR (DMSO-d6) δ /ppm: 7.97 (d, 1H, J = 5.2 Hz, 
NH), 7.42–7.30 (m, 10H, Ph), 5.70 (s, 1H, CH-Ph), 5.04 
(d, 1H, J = 3.2 Hz, H-1), 4.69 (d, 1H, J = 12.3 Hz, 
CH2b-Ph), 4.48 (d, 1H, J = 12.3 Hz, CH2a-Ph), 4.28 
(q,1H, J = 6.9 Hz, CH-CH3 lactyl), 4.14 (m, 1H, H-6b), 
3.80 (m, 1H, H-2), 3.77 (m, 1H, H-6a), 3.73 (m, 1H,  
H-3) 3.72 (m, 1H, H-2) 3.70 (m, 1H, H-5), 1.85 (s, 3H, 
CH3-CON acetyl), 1.27 (d, 3H, J = 6.9 Hz, CH-CH3 
lactyl); 13C NMR (DMSO-d6) δ /ppm: 175.2 (COOH), 
169.3 (CO acetyl), 137.6 (Ph(C)), 128.7–125.8 
(Ph(CH)), 100.2 (CH-Ph), 96.8 (C-1), 81.5 (C-4), 75.1 
(C-3), 75.0 (CH-CH3 lactyl), 68.9 (CH2-Ph), 67.8 (C-6), 
62.9 (C-5), 53.5 (C-2), 22.6 (CH3-CON), 18.6 (CH-CH3 
lactyl); MS-ESI m/z 472 [M+H]+. 
 
Benzyl 2-amino-4,6-O-benzylidene-3-O-[(R)-1-carboxy-
ethyl]-2-deoxy-α-D-glucopyranoside (5)19 
Compound 4 (2 g, 4.2 mmol) was dissolved in 5 M 
KOH in ethanol (28 mL). Reaction mixture was stirred 
16 h at 120 °C under nitrogen. Saturated solution of 
NH4Cl was added in reaction mixture and extracted with 
DCM (3 × 50 mL). Solvent was evaporated and crude 
product was purified on flash silica gel column chroma-
tography using solvent system E to elute impurities and 
solvent system C to give compound 5 (1.46 mg, 81 % 
yield). Rf (E) = 0.52; m.p. 175–176 °C; [α]D = +128 ° 
c 1, MeOH; 1H NMR (DMSO-d6) δ /ppm: 7.97 (d, 1H, 
J = 5.2 Hz, NH2), 7.43–7.30 (m, 10H, Ph), 5.68 (s, 1H, 
CH-Ph), 5.08 (d, 1H, J = 3.7 Hz, H-1), 4.69 (d, 1H, 
J = 11.8 Hz, CH2b-Ph), 4.57 (d, 1H, J = 11.8 Hz, CH2a-
Ph), 4.11 (m, 1H, H-6a), 3.91 (q, 1H, J = 7.0 Hz, CH-
CH3 lactyl), 3.72 (m, 1H, H-6b), 3.66 (m, 1H, H-4) 3.63 
(m, 1H, H-5), 3.61 (m, 1H, H-3), 3.11 (m, 1H, H-2), 
1.22 (d, 3H, J = 6.9 Hz, CH-CH3 lactyl); 13C NMR 
(DMSO-d6) δ /ppm: 175.7 (COOH), 137.3 (Ph(C)), 
128.8–125.8 (Ph(CH)), 100.2 (CH-Ph), 96.8 (C-1), 80.9 
(C-4), 78.6 (CH-CH3 lactyl), 76.8 (C-3), 69.4 (CH2-Ph), 
67.6 (C-6), 62.9 (C-5), 53.4 (C-2), 19.3 (CH-CH3 
lactyl); MS-ESI m/z 430 [M+H]+; HRMS calcd. for 
C23H28NO7 430.1860 found: 430.1849. 
 
Benzyl 2-amino-4,6-O-benzylidene-3-O-[(R)-1-carboxy-
ethyl]  - 2 - deoxy  - N - 9 - fluorenylmethyloxycarbonyl-α-D-
glucopyranoside (6) 
Compound 5 (1 g, 2.3 mmol) was dissolved in DMF (20 
mL) and sodium hydrogen carbonate (392 mg, 2 eq.) in 
water (20 mL) was added. Reaction mixture was kept  
at 0 °C and cold solution of Fmoc N-hydroxysuccinimide 
ester (Fmoc-OSu, 865 mg, 1.1 eq.) in DMF (20 mL) 
was added dropwise. Reaction was stirred in ice-water 
bath for 2 h. Water (100 mL) was added to the reaction 
mixture and formed precipitate was filtrate and washed 
with water. Product was evaporated under vacuum and 
then purified on flash silica gel column in solvent sys-
tem C which gave 1.35 g (90 % yield) of compound 6. 
Rf (C) = 0.48; m.p. 179–180 °C; [α]D = +71 ° c 1, DMF; 
1H NMR (DMSO-d6) δ /ppm: 7.95 (NH), 7.91–7.89 (m, 
2H, Fmoc), 7.75–7.71 (m, 2H, Fmoc), 7.43–7.28 (m, 
10H, Ph; 2H, Fmoc), 7.22–7.20 (m, 2H, Fmoc) 5.69  
(s, 1H, CH-Ph), 5.21 (d, 1H, J = 3.1 Hz, H-1), 4.69  
(d, 1H, J = 12.4 Hz, CH2b-Ph), 4.48 (d, 1H, J = 12.4 Hz, 
CH2a-Ph), 4.23 (m, CH2b-CH-Fmoc), 4.22 (m,  
CH-Fmoc), 4.15 (m, 1H, H-6a), 4.11 (m, CH2a-CH-
Fmoc), 4.10 (q, 1H, J = 7.0 Hz, CH-CH3 lactyl), 3.79 
(m, 1H, H-6b), 3.85 (m, 1H, H-3) 3.77 (m, 1H, H-4) 
3.71 (m, 1H, H-5), 3.44 (m, 1H, H-2), 1.26 (d, 3H, 
J = 7.4 Hz, CH-CH3 lactyl); 13C NMR (DMSO-d6) 
δ /ppm: 177.2 (COOH), 156.4 (CO Fmoc), 143.8 (Fmoc 
(C)),140.6 (Fmoc (C)), 137.7 (Ph (C)), 128.9–125.3  
(Ph (CH)), 120.1–120.0 (Fmoc (CH)), 100.21 (CH-Ph), 
96.7 (C-1), 82.56 (C-4), 77.5 (CH-CH3 lactyl), 72.8  
(C-3), 68.8 (CH2-Ph), 67.9 (C-6), 65.8 (CH2-CH Fmoc), 
63.1 (C-5), 55.8 (C-2), 46.6 (CH2-CH Fmoc), 19.3  
(CH-CH3 lactyl); MS-ESI m/z 674 [M+Na]+; HRMS 
calcd. for C38H37NO9Na 674.2360 found: 674.2372. 
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(S)-2-Chloropropionic acid (7)24 
L-Alanine (6 g, 0.067 mol) was dissolved in 8 M HCl 
(84 mL) and cooled to 0 °C and then solution of NaNO2 
(7.6 g in 24 mL water) in water was added dropwise 
with vigorous stirring. Temperature was kept at 5 °C for 
2 h, and after that the reaction mixture was stirred at  
2 °C for additional 4 h, and overnight at room tempera-
ture in inert conditions (under nitrogen). Sodium hydro-
gen carbonate (6.6 g) was added to the reaction mixture 
in small portions with vigorous stirring. Reaction was 
extracted with ether (2 × 50 mL, 1 × 30 mL) and collect-
ed ether’s extracts were washed with saturated soluti- 
on of calcium chloride (20 mL) and re-extracted with 
ether (30 mL). Ether’s extracts were dried for 2 h on 
calcium chloride. Ether was evaporated under reduced 
pressure and oil residue was distilled in vacuum to give 
pure (S)-2-chloropropionic acid (5.3 g, 73 % yield).  
b.p. 89 °C at p = 2.66 kPa; [α]D = –16.3 ° (lit. [α]D = 
–13.98 °)24; 1H NMR (CDCl3) δ /ppm: 1.74 (d, 3H,), 
4.45 (q, 1H,), 10.5 (s, 1H); 13C NMR (CDCl3) δ /ppm: 
21.3; 52.1; 176.0; MS-ESI m/z 153.1 [M+2Na]2+ (100 %); 
155.0 [M+2+2Na]2+ (32 %). 
 
RESULTS AND DISCUSSION 
The first three reaction steps were part of the established 
synthesis of N-acetylmuramic acid.25–29 The synthesis 
started from N-acetylglucosamine 1, which was protect-
ed by benzylation with benzyl alcohol at the anomeric 
position.19 The p-toluene sulfonic acid was used as a 
catalyst in the reaction which was carried out in toluene. 
The synthesis resulted in a α/β mixture of benzyl 
anomer 2, however the pure benzyl α-anomer 2 can be 
obtained with thermodynamic control of the reaction by 
high temperature in refluxing toluene.29 The incorpora-
tion of a benzylidene protection group in the 4-O and  
Table 1. NMR data (δ in ppm) of compounds 4–6 in DMSO-d6 
Position 
1H NMR  13C NMR 
4 5 6  4 5 6 
CH-1 5.04 5.08 5.21  96.8 96.8 96.7 
CH-2 3.80 3.11 3.44  53.5 53.4 55.8 
CH-3 3.73 3.61 3.85  75.1 76.8 72.8 
CH-4 3.72 3.66 3.77  81.5 80.9 82.6 
CH-5 3.70 3.63 3.71  62.9 62.9 63.1 
CH-6a 3.77 3.72 3.79  67.8 67.6 67.9 
CH-6b 4.14 4.11 4.15  – – – 
CH-CH3 4.28 3.91 4.10  75.0 78.6 77.5 
CH-CH3 1.27 1.22 1.26  18.6 19.3 19.3 
CH3-CON 1.85    22.6   
CH2a-Ph 4.48 4.57 4.48  68.9 69.4 68.8 
CH2b-Ph 4.69 4.69 4.69  – – – 
CH-Ph 5.70 5.68 5.69  100.2 100.2 100.2 
Ph (CH) 7.30–7.42 7.32–7.43 7.28–7.43  125.8–128.7 125.8–128.8 125.3–128.9 
Ph (C) – – –  137.6 137.3 137.7 
NH 7.97 7.97 7.95  – – – 
CON – – –  169.3 – – 
COOH – – –  175.2 175.7 177.2 
CO-Fmoc – – –  – – 156.4 
Fmoc (C)       140.6;143.8 
Fmoc (CH)    7.71–7.91, 7.20–7.22    120.0–120.1 
CH2a-CH Fmoc   4.11    65.8 
CH2b-CH Fmoc   4.23    – 
CH2-CH Fmoc   4.22    46.6 
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6-O-hydroxy positions was carried out according to 
previously published Gross and Jeanloz strategy to 
afford protected N-acetylglucosamine derivative 3 with 
a free 3-hydroxy group.21 The method for the effici- 
ent and easy synthesis of 4,6-benzylidne-derivative of 
N-acetylglucosamine, using pyridinium perchlorate as 
catalyst in the reaction with benzaldehyde dimethyla-
cetal, was recently published.30 By treating 3 with opti-
cally pure (S)-2-chloropropionic acid 7, the Williamson 
stereoselective ether synthesis proceeded in good yield 
(78 %), to afford 4.31 The synthesis of muramic acid 
previously reported in the literature is based on conden-
sation of D-glucosamine derivatives with a 2-halogeno-
propionic acid derivative, forming an ether link with the 
hydroxyl group at C-3.23,31 In most of these approaches, 
methyl 2 - acetamido - 4,6 - O - benzylidene - 2 - deoxy - α -D-
glucopyranoside or benzyl 2-acetamido-4,6-O-benzyli-
dene-2-deoxy-α-D-glucopyranoside (3) have been used 
as a starting material. However, alkylation of the unpro-
tected 3-O group of 3 with racemic 2-halogeno-propio-
nic acid derivatives led to the formation of a mixture of 
epimeric (R) and (S) ethers (muramic and isomuramic 
acid derivatives), and the described methods require 
additional separation of the epimeric mixture in order to 
obtain pure diastereomers.32 Improvement in the synthe-
sis of muramic acid was achieved by the use of enanti-
opure (S)-2-chloropropionic acid 7 as the alkylation 
agent in the critical condensation step.23 It was found 
that when (S)-2-chloropropionic acid was condensed 
with an alkoxide, it underwent Walden inversion.33 
Therefore, the condensation of 3 with pure (S)-2-chloro-
propionic acid led stereospecifically to muramic acid, 
with (R) configuration of the lactic acid moiety. Alt-
hough this method avoids chromatographic separation 
of 4, it was not explored due to the difficult preparation 
of optically pure reagent.32 Our modified approach for 
(S)-2-chloropropionic acid synthesis from (S)-alanine 24 
resulted in the optically pure compound 7 in 73 % yield. 
The introduction of lactic acid moiety was achieved in 
presence of NaH according to the paper published by 
Sinaÿ et al. for the synthesis of manno derivative of 
muramic acid with some modification in time, tempera-
ture and purification of compound.34 The compound 4 
was purified by flash chromatography and the stereose-
lectivity of the reaction was determined by 1H NMR. 
The benzylidene proton at 5.68 ppm for the muramic 
acid derivative 4 is indicative of the muramic acid de-
rivative with the (R)-configuration of the lactyl side-
chain according to the published data by Babič and 
Pečar which are for the muramic acid 5.66 ppm and for 
the isomuramic acid 5.55 ppm.29 The determination of 
the absolute configuration was especially important in 
the next step in the reaction of saponification of the 
compound 4, to deprotect amino group and give com-
pound 5. This reaction conditions enable racemisation. 
1H NMR analysis shows benzylidene proton of com-
pound 5 at 5.68 ppm (Table 1) which in comparison to 
compound 4 showed that we did not lose the optical 
purity in compound 5 with the (R) configuration of the 
lactyl group. The introduction of the Fmoc protecting 
group, the major group that enables utilisation of mu-
ramic acid in SPPS, was obtained with Fmoc-OSu in 
DMF/water solvent mixture with sodium hydrogen 
carbonate under low temperature (0 °C) to avoid by-
products formation. The synthesis with Fmoc-Cl as 
reagent was also examined but the reaction yields were 
poor. Upon the completion of the reaction the product  
6 was precipitated with water, filtrated and purified  
on silica gel column in solvent system C. The optical 
purity was confirmed by 1H NMR analysis which shows 
single signal for benzylidene proton of compound 6  
at 5.69 ppm (Table 1) which is in agreement with chem-
ical shifts of compound 4 (5.70 ppm, Table 1) and  
compound 5 (5.68 ppm, Table 1), respectively, for  
(R)-configuration of the lactyl group. Synthesised  
Fmoc protected muramic acid can be used in SPPS as 
 
Figure 2. Fragmentation pattern of compound 5.  
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dipeptide isostere building block. Protecting groups are 
necessary during the synthesis especially for synthesis 
of longer peptides to avoid by-products formation and to 
facilitate product purification. Orthogonal protection of 
muramic acid allows removal of Fmoc protecting group 
during peptide synthesis, while benzylidene group and 
benzyl protecting group can be easily removed after 
peptide condensation under acidic conditions and cata-
lytic hydrogenolysis.  
 
MS/MS fragmentation of prepared compounds 
Electrospray ionization (ESI) as soft-ionization method 
was used to determine the mass spectrometric properties 
of prepared compounds. The MS/MS fragmentation of 
all synthesised compounds from 2–6 showed the same 
tendency. The elimination of benzyl protecting group 
from 1-O of compounds 2–6 was confirmed with fol-
lowing detected fragments 204 (2), 292 (3), 364 (4), 322 
(5, Figure 2) and 544 (6, Figure 3) Da, for each com-
pound, respectively.35,36 The fragments 258 (4), 216 (5, 
figure 2) and 366 (6, Figure 3) Da are results of benzyl-
idene protecting group elimination. Further most intense 
signal in MS/MS spectrum of compound 5 is 182 which 
response to the lactone structure shown on Figure 2. 
Fragmentation of compound 6 in positive mode com-
pletely differs from that one in negative mode. While 
positive mode shows the elimination of protecting 
groups as well as dehydration of molecule, in negative 
mode the main and only observed fragment was 428 Da 
which responding to the Fmoc deprotected molecule 
(Figure 3). 
 
CONCLUSION 
In this work we reported simple and efficient synthesis 
of orthogonally protected muramic acid suitable for 
Fmoc solid-phase peptide synthesis. The advantages of 
our approach include simplified synthesis, use of readily 
available starting materials and high yield (~ 70–90 %) 
of desired optically pure (R)-isomers of products 4–6. 
The described synthesis of orthogonally protected mu-
ramic acid building blocks will allow an access to a 
variety of linear and cyclic peptides with unique struc-
tural properties and consequently biological activities. 
 
Figure 3. Fragmentation pattern of compound 6. 
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Compound 4:  
 
 
SpinWorks 2.5:   Vlahovicek D4/77/mur
PPM   7.6     7.2     6.8     6.4     6.0     5.6     5.2     4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4   -0.0   
file: G:\DOKTORAT_2015\NMR_Fmoc_Mur_(Bn)\NMR_D4_77Mur\1\fid   expt: <zg30>
transmitter freq.: 600.135401 MHz
time domain size: 32768 points
width: 12019.23 Hz = 20.027532 ppm = 0.366798 Hz/pt
number of scans: 86
freq. of 0 ppm: 600.129999 MHz
processed size: 32768 complex points
LB:    0.000    GB: 0.0000
SpinWorks 2.5:   Vlahovicek D4/77/mur
PPM   170.0    160.0    150.0    140.0    130.0    120.0    110.0    100.0    90.0     80.0     70.0     60.0     50.0     40.0     30.0     20.0     10.0   
file: G:\DOKTORAT_2015\NMR_Fmoc_Mur_(Bn)\NMR_D4_77Mur\5\fid   expt: <jmod>
transmitter freq.: 150.917899 MHz
time domain size: 65536 points
width: 39370.08 Hz = 260.870838 ppm = 0.600740 Hz/pt
number of scans: 10143
freq. of 0 ppm: 150.902884 MHz
processed size: 32768 complex points
LB:    0.000    GB: 0.0000
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Compound 5:  
 
 
SpinWorks 2.5:   K. Vlahovicek D5_63_2
PPM   7.2     6.8     6.4     6.0     5.6     5.2     4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4   -0.0   
file: G:\DOKTORAT_2015\NMR_Fmoc_Mur_(Bn)\NMR_skodanje_Ac\1\fid   expt: <zg30>
transmitter freq.: 300.132701 MHz
time domain size: 32768 points
width:  6172.84 Hz = 20.567034 ppm = 0.188380 Hz/pt
number of scans: 32
freq. of 0 ppm: 300.130001 MHz
processed size: 32768 complex points
LB:    0.000    GB: 0.0000
SpinWorks 2.5:   K. Vlahovicek D4/83
PPM   170.0    160.0    150.0    140.0    130.0    120.0    110.0    100.0    90.0     80.0     70.0     60.0     50.0     40.0     30.0     20.0     10.0   
file: G:\DOKTORAT_2015\NMR_Fmoc_Mur_(Bn)\NMR_D4_83_skidanje_acetila\5\fid   expt: <jmod>
transmitter freq.: 150.917899 MHz
time domain size: 65536 points
width: 39370.08 Hz = 260.870838 ppm = 0.600740 Hz/pt
number of scans: 10302
freq. of 0 ppm: 150.902884 MHz
processed size: 32768 complex points
LB:    0.000    GB: 0.0000
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Compound 6:  
 
 
SpinWorks 2.5:   K. Vlahovicek-Kahlina D4/93
PPM   7.6     7.2     6.8     6.4     6.0     5.6     5.2     4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4   -0.0   
file: G:\DOKTORAT_2015\NMR_Fmoc_Mur_(Bn)\NMR_D4_93_Fmoc_Mur\1\fid   expt: <zg30>
transmitter freq.: 600.135401 MHz
time domain size: 32768 points
width: 12019.23 Hz = 20.027532 ppm = 0.366798 Hz/pt
number of scans: 64
freq. of 0 ppm: 600.129998 MHz
processed size: 32768 complex points
LB:    0.000    GB: 0.0000
SpinWorks 2.5:   K. Vlahovicek-Kahlina D4/93
PPM   150.0    140.0    130.0    120.0    110.0    100.0    90.0     80.0     70.0     60.0     50.0     40.0     30.0     20.0     10.0   
file: G:\DOKTORAT_2015\NMR_Fmoc_Mur_(Bn)\NMR_D4_93_Fmoc_Mur\5\fid   expt: <jmod>
transmitter freq.: 150.917899 MHz
time domain size: 65536 points
width: 39370.08 Hz = 260.870838 ppm = 0.600740 Hz/pt
number of scans: 10349
freq. of 0 ppm: 150.902884 MHz
processed size: 32768 complex points
LB:    0.000    GB: 0.0000
